Ability of KBTBD10 to inhibit non-small cell lung cancer mediated by LINC01585.
A multilayered regulatory signaling axis linking the immunogenomic microenvironment to NSCLC progression is delineated, which provides mechanistic insights and translational implications for developing immunotherapeutic strategies targeting KBTBD10, LINC 01585, and LINC 01585 in NSCLC treatment.